[
  {
    "ts": null,
    "headline": "Should You Reconsider Centene After Judges Uphold Medicare Drug Price Negotiation Program?",
    "summary": "Trying to figure out what to do with Centene stock right now? You are not alone. The company has seen some eye-catching price moves lately that might have investors feeling both excited and a bit jittery. Over just the past week, Centene’s shares jumped nearly 15%, and they are up a hefty 22.9% across the past month. That kind of momentum definitely turns heads, especially when you consider that, just a short while ago, the stock was deep in the red on a one-year and even longer-term basis,...",
    "url": "https://finnhub.io/api/news?id=dce9bcc3740f8528978b71b24db18565e7c180d4883ac213a0871592be6ad56b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1757770928,
      "headline": "Should You Reconsider Centene After Judges Uphold Medicare Drug Price Negotiation Program?",
      "id": 136736259,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CNC",
      "source": "Yahoo",
      "summary": "Trying to figure out what to do with Centene stock right now? You are not alone. The company has seen some eye-catching price moves lately that might have investors feeling both excited and a bit jittery. Over just the past week, Centene’s shares jumped nearly 15%, and they are up a hefty 22.9% across the past month. That kind of momentum definitely turns heads, especially when you consider that, just a short while ago, the stock was deep in the red on a one-year and even longer-term basis,...",
      "url": "https://finnhub.io/api/news?id=dce9bcc3740f8528978b71b24db18565e7c180d4883ac213a0871592be6ad56b"
    }
  }
]